Julie Schanz
A5011302710- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Lymphoma Diagnosis and Treatment
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Hematological disorders and diagnostics
- Acute Lymphoblastic Leukemia research
- Chronic Lymphocytic Leukemia Research
- Immunodeficiency and Autoimmune Disorders
- Cancer Genomics and Diagnostics
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Hematopoietic Stem Cell Transplantation
- Genomic variations and chromosomal abnormalities
- Sarcoma Diagnosis and Treatment
- Multiple Myeloma Research and Treatments
- Eosinophilic Disorders and Syndromes
- Vascular Tumors and Angiosarcomas
- Advanced biosensing and bioanalysis techniques
- Clinical Laboratory Practices and Quality Control
- Blood disorders and treatments
- Cardiac tumors and thrombi
- CNS Lymphoma Diagnosis and Treatment
- Influenza Virus Research Studies
- Platelet Disorders and Treatments
- Autoimmune and Inflammatory Disorders
Universitätsmedizin Göttingen
2015-2024
University of Göttingen
2012-2023
Palmetto Hematology Oncology
2023
Nephrologisches Zentrum Goettingen
2015
Heinrich Heine University Düsseldorf
2011
Medical University of Vienna
2011
Austrian Breast & Colorectal Cancer Study Group
2010
Klinikum Ludwigshafen
2009
RELX Group (Netherlands)
2004
Hy-Line (United States)
2004
Purpose The karyotype is a strong independent prognostic factor in myelodysplastic syndromes (MDS). Since the implementation of International Prognostic Scoring System (IPSS) 1997, knowledge concerning impact abnormalities has increased substantially. present study proposes new and comprehensive cytogenetic scoring system based on an international data collection 2,902 patients. Patients Methods were included from German-Austrian MDS Study Group (n = 1,193), Risk Analysis Workshop 816),...
// Peter Valent 1,2 , Attilio Orazi 3 David P. Steensma 4 Benjamin L. Ebert 5 Detlef Haase 6 Luca Malcovati 7 Arjan A. van de Loosdrecht 8 Torsten Haferlach 9 Theresia M. Westers Denise Wells 10 Aristoteles Giagounidis 11 Michael Loken Alberto Orfao 12 Lübbert 13 Arnold Ganser 14 Wolf-Karsten Hofmann 15 Kiyoyuki Ogata 16 Julie Schanz Marie C. Béné 17 Gregor Hoermann 18 Wolfgang R. Sperr Karl Sotlar 19 Bettelheim 20 Reinhard Stauder 21 Pfeilstöcker 22 Hans-Peter Horny...
The International Prognostic Scoring System (IPSS) remains the most commonly used system for risk classification in myelodysplastic syndromes (MDSs). IPSS gives more weight to blast count than cytogenetics. However, previous publications suggested that cytogenetics are underweighted IPSS. Here we investigate prognostic impact of cytogenetic subgroups compared with bone marrow a large, multicentric, international patient cohort.In total, 2,351 patients MDS who have records German-Austrian and...
Loss of the Y‐chromosome (LOY) is described as both a normal age‐related event and marker neoplastic clone in hematologic diseases. To assess significance LOY myelodysplastic syndromes (MDS), we determined percentage clonal CD34+ peripheral blood cells comparison to CD3+ T‐cells 27 MDS patients using fluorescence situ hybridization (FISH) analysis. Results were compared with 32 elderly men without diseases 25 young donors. While could not be detected men, it was observed (2.5% LOY) well...
Abstract Background Homologous and heterologous SARS‐CoV‐2 vaccinations yield different spike protein‐directed humoral cellular immune responses. This study aimed to explore their currently unknown interdependencies. Methods COV‐ADAPT is a prospective, observational cohort of 417 healthcare workers who received vaccination with homologous ChAdOx1 nCoV‐19, BNT162b2 or nCoV‐19/BNT162b2. We assessed (anti‐spike‐RBD‐IgG, neutralizing antibodies, avidity) (spike‐induced T‐cell interferon‐γ...